Junseon Min

发表

An enhanced ascorbate peroxidase 2/antibody-binding domain fusion protein (APEX2-ABD) as a recombinant target-specific signal amplifier.

Moonil Kim, Hyun-Woo Rhee, Eun Kyung Song, 2015, Chemical communications.

Concentration-Independent Multivalent Targeting of Cancer Cells by Genetically Encoded Core-Crosslinked Elastin/Resilin-like Polypeptide Micelles.

A. Chilkoti, Michael Dzuricky, P. Weber, 2021, Biomacromolecules.

A Quantitative Study of the Interaction of Multivalent Ligand-Modified Nanoparticles with Breast Cancer Cells with Tunable Receptor Density.

R. Kane, A. Chilkoti, Jing Wang, 2020, ACS nano.

A Recombinant Secondary Antibody Mimic as a Target-specific Signal Amplifier and an Antibody Immobilizer in Immunoassays

Eun Kyung Song, Kyoung Taek Kim, Sebyung Kang, 2016, Scientific Reports.

Synthetic ribonucleoprotein granules regulate translation of a target mRNA in living cells

A. Chilkoti, C. Gersbach, Yifan Dai, 2022 .

Development of an antibody-binding modular nanoplatform for antibody-guided targeted cell imaging and delivery

Sebyung Kang, Hyeokjune Choi, Han-ul Kim, 2016 .

Genetically engineering encapsulin protein cage nanoparticle as a SCC-7 cell targeting optical nanoprobe

Sebyung Kang, Hansol Kim, Jisu Lee, 2014, Biomaterials Research.

Lumazine synthase protein cage nanoparticles as modular delivery platforms for targeted drug delivery

S. Kim, Sebyung Kang, Jisu Lee, 2014 .

Developing genetically engineered encapsulin protein cage nanoparticles as a targeted delivery nanoplatform.

Sebyung Kang, Jisu Lee, Junseon Min, 2014, Biomacromolecules.

Implementation of P22 viral capsids as intravascular magnetic resonance T1 contrast conjugates via site-selective attachment of Gd(III)-chelating agents.

Hyungjoon Cho, G. Cho, Sebyung Kang, 2013, Biomacromolecules.

Development of P22 viral capsid nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms.

Sung You Hong, Hyun-Ji Yang, Sebyung Kang, 2014, Macromolecular bioscience.